20-22581952-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_021784.5(FOXA2):c.1290G>A(p.Met430Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,612,348 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )
Consequence
FOXA2
NM_021784.5 missense
NM_021784.5 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 7.82
Genes affected
FOXA2 (HGNC:5022): (forkhead box A2) This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 28 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXA2 | NM_021784.5 | c.1290G>A | p.Met430Ile | missense_variant | 2/2 | ENST00000419308.7 | NP_068556.2 | |
FOXA2 | NM_153675.3 | c.1272G>A | p.Met424Ile | missense_variant | 3/3 | NP_710141.1 | ||
FOXA2 | XM_047440133.1 | c.1272G>A | p.Met424Ile | missense_variant | 3/3 | XP_047296089.1 | ||
FOXA2 | XM_047440134.1 | c.1182G>A | p.Met394Ile | missense_variant | 2/2 | XP_047296090.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXA2 | ENST00000419308.7 | c.1290G>A | p.Met430Ile | missense_variant | 2/2 | 1 | NM_021784.5 | ENSP00000400341 | P4 | |
FOXA2 | ENST00000377115.4 | c.1272G>A | p.Met424Ile | missense_variant | 3/3 | 1 | ENSP00000366319 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152190Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
28
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250838Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135582
GnomAD3 exomes
AF:
AC:
8
AN:
250838
Hom.:
AF XY:
AC XY:
1
AN XY:
135582
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460158Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 725972
GnomAD4 exome
AF:
AC:
12
AN:
1460158
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
725972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74334
GnomAD4 genome
AF:
AC:
28
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.1290G>A (p.M430I) alteration is located in exon 2 (coding exon 2) of the FOXA2 gene. This alteration results from a G to A substitution at nucleotide position 1290, causing the methionine (M) at amino acid position 430 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Polyphen
0.96
.;D
Vest4
MutPred
0.68
.;Loss of disorder (P = 0.0297);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at